Search Results - "Alexandrova, E N"

Refine Results
  1. 1
  2. 2

    Effects of combined sonodynamic and photodynamic therapies with photolon on a glioma C6 tumor model by Tserkovsky, D A, Alexandrova, E N, Chalau, V N, Istomin, Yu P

    Published in Experimental oncology (01-12-2012)
    “…The aim of this study was to investigate the low-power density sonication, sonodynamic therapy (SDT) with Photolon and combination of SDT and photodynamic…”
    Get more information
    Journal Article
  3. 3

    PHOTODYNAMIC THERAPY IN MULTIMODALITY TREATMENT OF PLISS LYMPHOSARCOMA AND UTERINE CERVIX CANCER-5 by Vasileuski, A. P., Artemova, N. A., Litvinova, T. M., Kosenko, I. A., Alexandrova, E. N.

    “…Background. Malignant tumors management using conventional treatment modalities is associated with poor outcomes. Objective of the study. To assess…”
    Get full text
    Journal Article
  4. 4

    Clinical associations of vascular endothelial growth factor in patients with systemic sclerosis by Alekperov, R. T., Alexandrova, E. N., Novikov, A. A., Ananyeva, L. P.

    Published in Alʹmanakh klinicheskoĭ medit͡s︡iny (31-01-2018)
    “…Aim: To assess serum levels of vascular endothelial growth factor (VEGF) and its clinical correlates in patients with systemic sclerosis (SSc). Materials and…”
    Get full text
    Journal Article
  5. 5

    Fluorescent diagnosis and photodynamic therapy for C6 glioma in combination with antiangiogenic therapy in subcutaneous and intracranial tumor models by Tzerkovsky, D A, Osharin, V V, Istomin, Y P, Alexandrova, E N, Vozmitel, M A

    Published in Experimental oncology (01-06-2014)
    “…Investigating the distinctions pharmacokinetics of chlorin e6 conjugated with polyvinyl pyrrolidone photosensitizer (Ce6CPPPS)in healthy and tumor tissues of…”
    Get more information
    Journal Article
  6. 6

    Photolon enhancement of ultrasound cytotoxicity by Tserkovsky, D A, Alexandrova, E N, Istomin, Yu P

    Published in Experimental oncology (01-06-2011)
    “…To evaluate the impact of Photolon on cytostatic and cytotoxic effects of therapeutic range ultrasound in C6 glioma cells. C6 glioma cells in suspension or…”
    Get more information
    Journal Article
  7. 7

    AMYLOIDOSIS HEART IN ELDERLY by Dvoretsky, L. I., Karpova, O. Yu, Alexandrova, E. N., Petrova, S. Yu

    Published in Arkhivʺ vnutrenneĭ medit͡s︡iny (28-12-2015)
    “…The data on the incidence, clinical presentation, diagnostic methods amyloidosis of the heart in different types of amyloidosis. The features of the current…”
    Get full text
    Journal Article
  8. 8

    Features of systemic sclerosis-rheumatoid arthritis overlap syndrome (SS-RA overlap syndrome) by Desinova, O. V., Starovoytova, M. N., Guseva, I. A., Novikov, A. A., Alexandrova, E. N., Guseva, N. G.

    “…Objective. To reveal clinico-laboratory, immunologic and immunogenetic features of systemic sclerosis-rheumatoid arthritis overlap syndrome (SS-RA).Material…”
    Get full text
    Journal Article
  9. 9

    Antibodies to annexin-5 in pregnant women with systemic lupus erythematosus by Alekberova, Z. S., Kosheleva, N. M., Alexandrova, E. N., Husmieva, S. I., Novikov, A. A., Nasonov, E. L.

    “…Objective. To assess change of annexin-5 antibodies (AA5) level and AA5 influence on gestation outcome in pregnant women with systemic lupus erythematosus…”
    Get full text
    Journal Article
  10. 10

    Early arthritis in children – first results of prospective follow up by Salugina, S. O., Kuzmina, N. N., Movsisyan, G. R., Fedorov, E. S., Arsenjeva, S. V., Alexandrova, E. N., Novikov, A. A., Baranov, A. A.

    “…Objective. To perform a prospective investigation of clinico-laboratory and sonographic picture of juvenile arthritis (JA) onset, to follow up its evolution…”
    Get full text
    Journal Article
  11. 11

    Clinical significance of high-sensitivity C- reactive protein in systemic sclerosis by Nevskaya, T. A., Novikov, A. A., Alexandrova, E. N., Mach, E. S., Zapryagaeva, M. E., Speransky, A. I., Guseva, N. G., Ananjeva, L. P.

    “…Objective. To determine diagnostic and prognostic significance of high-sensitivity Creactive protein (hsCRP) in systemic sclerosis (SS), to define relationship…”
    Get full text
    Journal Article
  12. 12

    Dose enhancement effect of anticaner drugs associated with increased temperature in vitro by Istomin, Yu P, Zhavrid, E A, Alexandrova, E N, Sergeyeva, O P, Petrovich, S V

    Published in Experimental oncology (01-03-2008)
    “…To evaluate in vitro the influence of elevated temperature (42 degrees C for 60 min) on the action of anticancer drugs doxorubicin, vinorelbine, carboplatin,…”
    Get more information
    Journal Article
  13. 13

    The effect of cytostatics and hyperthermia on RAJI human lymphoma cells by Istomin, Yu P, Zhavrid, E A, Sachivko, N V, Alexandrova, E N, Pocheshinsky, P V

    Published in Experimental oncology (01-03-2011)
    “…To evaluate the effect of hyperthermia on cytostatic activity of chemotherapeutic drugs carboplatin, cisplatin, oxaliplatin, carmustine, gemcitabine and…”
    Get more information
    Journal Article
  14. 14

    DEVELOPMENT OF A REAL-TIME RT-PCR-BASED TEST PANEL FOR ASSESSMENT OF CYTOKINE PROFILE IN MONONUCLEAR CELLS FROM BLOOD AND SYNOVIAL FLUID IN RHEUMATOID ARTHRITIS by Trofimov, D. Yu, Burmenskaya, O. V., Bateneva, E. I., Alexeev, L. P., Nasonov, E. L., Alexandrova, E. N., Novikov, A. A.

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (18-07-2014)
    “…An imbalance between pro- and anti-inflammatory cytokine synthesis plays a crucial role in pathogenesis of rheumatoid arthritis (RA), including erosive joint…”
    Get full text
    Journal Article
  15. 15

    RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH PSORIATIC ARTHRITIS by Badokin, V. V., Troshkina, I. A., Alexandrova, E. N.

    “…Objective: to define the clinical value of rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (anti-CCP) in early psori- atic arthritis…”
    Get full text
    Journal Article
  16. 16

    IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS by Avdeeva, Anastasia Sergeevna, Smirnov, A V, Panasyuk, E Yu, Alexandrova, E N, Nasonov, E L

    “…Objective — to evaluate the impact of tocilizumab (TCZ) therapy on progression of joint destruction and rheumatoid arthritis (RA) inflammatory activity in 48…”
    Get full text
    Journal Article
  17. 17

    The levels of plasminogen and inhibitor of plasminogen activators of type 1 in antiphospholipid syndrome by E V Ostryakova, T M Reshetnyak, R B Aisina, L I Mukhametova, D A Gulin, E N Alexandrova, N V Seredavkina, S D Varfolomeev, A V Chernyakov, Yu V Nikiforov, E L Nasonov

    Published in Terapevtic̆eskii arhiv (01-01-2012)
    “…To estimate the levels of of plasminogen (Pg) and inhibitor of plasminogen activators of type 1 (IPA-1) in patients with antiphospholipid syndrome (APS) and to…”
    Get full text
    Journal Article
  18. 18

    Photodynamic efficacy of topical application of chlorin e6--polyvinyl pyrrolidone complex in tumor-bearing rats by Istoin, Y P, Laptsevich, T P, Bizyuk, S A, Alexandrova, E N

    Published in Experimental oncology (01-12-2006)
    “…To evaluate the antitumor efficacy of photodynamic therapy with ointment form of chlorin e6--polyvinyl pyrrolidone complex. 2 or 5% chlorin e6 ointment was…”
    Get more information
    Journal Article
  19. 19

    Pleiotropic effects of statins in systemic sclerosis by Alekperov, R T, Korzeneva, E G, Aleksandrova, E N, Novikov, A A, Anan'eva, L P

    Published in Terapevtic̆eskii arhiv (01-01-2011)
    “…To study anti-inflammatory and angioprotective properties of statins in patients with systemic sclerosis (SS). Fifty SS patients enrolled in the trial were…”
    Get full text
    Journal Article
  20. 20

    Ten-year risk of cardiovascular complications in patients with rheumatoid arthritis by Gerasimova, E V, Popkova, T V, Novikova, D S, Aleksandrova, E N, Novikov, A A, Nasonov, E L

    Published in Terapevtic̆eskii arhiv (01-01-2011)
    “…To compare 10-year risk of cardiovascular complications (CVC) assessed by Adult Treatment Panel III (ATP III) and Reynolds Risk Score (RRS); to specify…”
    Get full text
    Journal Article